Is the diagnosis of Cushing disease moving beyond bilateral inferior petrosal sinus sampling?
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgag265 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Louise Bouchard und 11 weiteren Autor:innen. Beteiligte Einrichtung: University Grenoble Alpes, CHU Grenoble Alpes, Endocrinology Unit, Grenoble 38000, France. Hauptthemen laut MEDLINE: Petrosal Sinus Sampling, Pituitary ACTH Hypersecretion, ACTH Syndrome, Ectopic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Background and objective Bilateral inferior petrosal sinus sampling (BIPSS) is the gold standard for distinguishing Cushing disease (CD) from ectopic ACTH syndrome (EAS). It is, however, rarely evaluated in an intent-to-diagnose analysis, even though the final diagnosis remains inconclusive in 7% to 39% of patients in published series. It has been suggested that BIPSS use may be reduced in patients explored by modern imaging and hormonal testing. We tested this hypothesis. Design and methods Evolution of BIPSS use and diagnostic outcomes over time in a single-center retrospective study of 229 consecutive patients with ACTH-dependent Cushing syndrome without evident endocrine tumors, explored from 1992 to 2021 with hormonal testing (n = 229), pituitary magnetic resonance imaging (MRI; n = 226) or computed tomography (CT; n = 3), chest/abdominal CT scan (n = 114), and BIPSS (n=113). In an intent-to-diagnose analysis, we classified outcomes as confirmed CD (cCD) or confirmed ectopic ACTH syndrome (cEAS) if there was post therapeutic evidence of an ACTH-secreting tumor and as suspected CD (sCD) or suspected ectopic ACTH syndrome (sEAS) if not, resulting in 196 cCD (86%), 24 sCD (10%), 5 cEAS (2%), and 4 sEAS (2%).
Results
Comparing the 3 decades 1992-2001, 2002-2011, and 2012-2021, the use of BIPSS decreased from 68% to 49% and 26%, while the frequency of a typical adenoma image at MRI increased from 40% to 58% and 69%. The proportion of patients with cCD (83%, 81%, and 93%, respectively) remained stable.
Conclusion
Our study demonstrates a decrease over time in the use of BIPSS without loss of efficacy in the diagnosis of CD, suggesting that advances in imaging allow for a safe reduction in the indications for BIPSS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Grenoble Alpes, CHU Grenoble Alpes, Endocrinology Unit, Grenoble 38000, France.
- University Grenoble Alpes, CHU Grenoble Alpes, Neurosurgery Unit, Grenoble 38000, France.
- University Grenoble Alpes, CHU Grenoble Alpes, Neuroradiology Unit, Grenoble 38000, France.
- Clinique du Mail, Grenoble 38000, France.
- Pathology Department, University Grenoble Alpes, CHU Grenoble Alpes, Grenoble 38000, France.
- IBP, University of Grenoble Alpes, CHU Grenoble Alpes, Hormonal Biochemistry Unit, Grenoble 38000, France.
ORCID-Profile: Arnaud Lazard, Patrice Faure, Marie Muller, Olivier Chabre, Justine Cristante
Zitieren
APA
Bouchard, L., Lazard, A., Jean, C., Heck, O., Lefournier, V., Sturm, N., Chovelon, B., Faure, P., Muller, M., Gay, E., Chabre, O., & Cristante, J. (2026). Is the diagnosis of Cushing disease moving beyond bilateral inferior petrosal sinus sampling?. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag265
Vancouver
Bouchard L, Lazard A, Jean C, Heck O, Lefournier V, Sturm N, et al. Is the diagnosis of Cushing disease moving beyond bilateral inferior petrosal sinus sampling?. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag265
BibTeX
@article{Bouchard2026,
author = {Bouchard, Louise and Lazard, Arnaud and Jean, Clément and Heck, Olivier and Lefournier, Virginie and Sturm, Nathalie and Chovelon, Benoit and Faure, Patrice and Muller, Marie and Gay, Emmanuel and Chabre, Olivier and Cristante, Justine},
title = {Is the diagnosis of Cushing disease moving beyond bilateral inferior petrosal sinus sampling?},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag265}
}
EUVIMED